{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:14:34Z","timestamp":1780082074097,"version":"3.54.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1124\/dmd.116.073239","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T03:10:39Z","timestamp":1481166639000},"page":"316-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Stereoselective Pharmacokinetics and Chiral Inversion of Ibuprofen in Adjuvant-induced Arthritic Rats"],"prefix":"10.1016","volume":"45","author":[{"given":"Hiroyuki","family":"Ikuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.116.073239_bib1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-3565(25)22618-0","article-title":"Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition","volume":"240","author":"Abas","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.073239_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.2042-7158.1976.tb04144.x","article-title":"Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer","volume":"28","author":"Adams","year":"1976","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1023\/A:1015866704848","article-title":"Stereoselective systemic disposition of ibuprofen enantiomers in the dog","volume":"8","author":"Ahn","year":"1991","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.116.073239_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)23426-7","article-title":"Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans","volume":"249","author":"Baillie","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.073239_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1025719827072","article-title":"Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study","volume":"25","author":"Borg\u00e5","year":"1997","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.116.073239_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003088-199426040-00003","article-title":"Etodolac clinical pharmacokinetics","volume":"26","author":"Brocks","year":"1994","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.116.073239_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/j.1552-4604.1992.tb04643.x","article-title":"Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology","volume":"32","author":"Brune","year":"1992","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib8","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1124\/dmd.111.041640","article-title":"Production of ibuprofen acyl glucosides by human UGT2B7","volume":"39","author":"Buchheit","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-2952(88)90762-9","article-title":"The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences","volume":"37","author":"Caldwell","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/tvjl.2001.0584","article-title":"Disposition of suprofen enantiomers in the cat","volume":"162","author":"Castro","year":"2001","journal-title":"Vet J"},{"key":"10.1124\/dmd.116.073239_bib11","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1124\/dmd.108.022970","article-title":"Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro","volume":"36","author":"Chang","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-4165(90)90185-Y","article-title":"Metabolic stereoisomeric inversion of 2-arylpropionic acids. On the mechanism of ibuprofen epimerization in rats","volume":"1033","author":"Chen","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.116.073239_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0167-4838(91)90164-U","article-title":"Metabolic stereoisomeric inversion of ibuprofen in mammals","volume":"1078","author":"Chen","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.116.073239_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2165\/00003088-199528020-00002","article-title":"Clinical pharmacokinetics of flurbiprofen and its enantiomers","volume":"28","author":"Davies","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.116.073239_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199834020-00002","article-title":"Clinical pharmacokinetics of ibuprofen. The first 30 years","volume":"34","author":"Davies","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.116.073239_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1015847912059","article-title":"The biliary elimination and enterohepatic circulation of ibuprofen in rats","volume":"7","author":"Dietzel","year":"1990","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.116.073239_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0090-9556(25)06837-0","article-title":"Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen","volume":"15","author":"el Mouelhi","year":"1987","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/bdd.2510110605","article-title":"The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans","volume":"11","author":"Evans","year":"1990","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.116.073239_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jps.2600770113","article-title":"Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses","volume":"77","author":"Foster","year":"1988","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073239_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-2952(97)00143-3","article-title":"Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C","volume":"54","author":"Hamman","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.2042-7158.1983.tb02874.x","article-title":"The metabolic chiral inversion of 2-arylpropionic acids--a novel route with pharmacological consequences","volume":"35","author":"Hutt","year":"1983","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/(SICI)1520-636X(1997)9:4<354::AID-CHIR7>3.0.CO;2-D","article-title":"Stereoselective pharmacokinetics of ibuprofen in rats: effect of enantiomer-enantiomer interaction in plasma protein binding","volume":"9","author":"Itoh","year":"1997","journal-title":"Chirality"},{"key":"10.1124\/dmd.116.073239_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0090-9556(25)06753-4","article-title":"Stereoselective disposition of naproxen glucuronide in the rat","volume":"23","author":"Iwaki","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jps.2600770805","article-title":"Stereoselective pharmacokinetics of flurbiprofen in humans and rats","volume":"77","author":"Jamali","year":"1988","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073239_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00003088-199019030-00004","article-title":"Clinical pharmacokinetics of ketoprofen and its enantiomers","volume":"19","author":"Jamali","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.116.073239_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jps.2600650222","article-title":"Isomeric inversion of ibuprofen (R)-enantiomer in humans","volume":"65","author":"Kaiser","year":"1976","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073239_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/dmd.106.011536","article-title":"Effects of alterations in CAR on bilirubin detoxification in mouse collagen-induced arthritis","volume":"35","author":"Kawase","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/00498254.2012.710350","article-title":"Alteration in plasma protein binding properties of propranolol and flurbiprofen during development of adjuvant-induced arthritis in rats","volume":"43","author":"Kawase","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.073239_bib29","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/jps.24043","article-title":"Distinct alterations in ATP-binding cassette transporter expression in liver, kidney, small intestine, and brain in adjuvant-induced arthritic rats","volume":"103","author":"Kawase","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073239_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/chir.530020202","article-title":"Stereoselective arylpropionyl-CoA thioester formation in vitro","volume":"2","author":"Knadler","year":"1990","journal-title":"Chirality"},{"key":"10.1124\/dmd.116.073239_bib31","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/0006-2952(91)90184-7","article-title":"Enhanced chiral inversion of R-ibuprofen in liver from rats treated with clofibric acid","volume":"41","author":"Knights","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib32","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1016\/0006-2952(89)90647-3","article-title":"Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--1. In vitro studies of ibuprofen and flurbiprofen","volume":"38","author":"Knihinicki","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/chir.530020303","article-title":"Stereoselective disposition of ibuprofen and flurbiprofen in rats","volume":"2","author":"Knihinicki","year":"1990","journal-title":"Chirality"},{"key":"10.1124\/dmd.116.073239_bib34","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/0006-2952(91)90588-V","article-title":"Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--II. Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioesters","volume":"42","author":"Knihinicki","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib35","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/jps.2600731112","article-title":"Liquid chromatographic determination and plasma concentration profile of optical isomers of ibuprofen in humans","volume":"73","author":"Lee","year":"1984","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073239_bib36","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0006-2952(94)90380-8","article-title":"Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion?","volume":"48","author":"Menzel","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0090-9556(24)14879-9","article-title":"Glucuronidation of R- and S-ketoprofen, acetaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats","volume":"27","author":"Meunier","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1023\/A:1018996018708","article-title":"Glucuronidation kinetics of R,S-ketoprofen in adjuvant-induced arthritic rats","volume":"16","author":"Meunier","year":"1999","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.116.073239_bib39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/00498257309151547","article-title":"The metabolism of ibuprofen","volume":"3","author":"Mills","year":"1973","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.073239_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/chir.530020203","article-title":"Metabolic chiral inversion of ibuprofen in isolated rat hepatocytes","volume":"2","author":"M\u00fcller","year":"1990","journal-title":"Chirality"},{"key":"10.1124\/dmd.116.073239_bib41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/chir.10227","article-title":"Stereoselective pharmacokinetics of flurbiprofen and formation of covalent adducts with plasma protein in adjuvant-induced arthritic rats","volume":"15","author":"Nagao","year":"2003","journal-title":"Chirality"},{"key":"10.1124\/dmd.116.073239_bib42","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/jpet.107.121491","article-title":"Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices","volume":"322","author":"Nozaki","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.073239_bib43","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"Carbon monoxide-binding pigment of liver microsomes. I: Evidence for its hemoprotein nature","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.116.073239_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0090-9556(25)07996-6","article-title":"A commentary: methods and assumptions in the kinetic estimation of metabolite formation","volume":"11","author":"Pang","year":"1983","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib45","first-page":"1170","article-title":"Stereochemical pharmacokinetics of the 2-arylpropionic acid non-steroidal antiinflammatory drug flunoxaprofen in rats and in man","volume":"38","author":"Pedrazzini","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/dmd.116.073239_bib46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02028122","article-title":"Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats","volume":"37","author":"Piquette-Miller","year":"1992","journal-title":"Agents Actions"},{"key":"10.1124\/dmd.116.073239_bib47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0090-9556(25)06525-0","article-title":"Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis","volume":"23","author":"Piquette-Miller","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0090-9556(25)08825-7","article-title":"Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats","volume":"17","author":"Pollock","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib49","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/mol.51.4.576","article-title":"Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen","volume":"51","author":"Reichel","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.116.073239_bib50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jps.2600740122","article-title":"Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans","volume":"74","author":"Rubin","year":"1985","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073239_bib51","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0022-3565(25)20501-8","article-title":"Stereoselective metabolism of ibuprofen in humans: administration of R-, S- and racemic ibuprofen","volume":"259","author":"Rudy","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.073239_bib52","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1016\/S0021-9258(18)53720-0","article-title":"Purification and characterization of novel \u201c2-arylpropionyl-CoA epimerases\u201d from rat liver cytosol and mitochondria","volume":"268","author":"Shieh","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.116.073239_bib53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/00498250210142994","article-title":"Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers","volume":"32","author":"Tan","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.073239_bib54","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/00498259409043263","article-title":"Effect of adjuvant-induced arthritis on hepatic drug metabolism in rats","volume":"24","author":"Toda","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.073239_bib55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0090-9556(25)08607-6","article-title":"Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A","volume":"20","author":"Tracy","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2133\/dmpk.22.313","article-title":"Decreased intestinal CYP3A and P-glycoprotein activities in rats with adjuvant arthritis","volume":"22","author":"Uno","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.116.073239_bib57","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/00498250802483768","article-title":"Impaired intrinsic chiral inversion activity of ibuprofen in rats with adjuvant-induced arthritis","volume":"38","author":"Uno","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.073239_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bdd.639","article-title":"Changes in mRNA expression of ABC and SLC transporters in liver and intestines of the adjuvant-induced arthritis rat","volume":"30","author":"Uno","year":"2009","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.116.073239_bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0090-9556(25)08862-2","article-title":"Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat","volume":"14","author":"Walker","year":"1986","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073239_bib60","first-page":"42","article-title":"Rheumatoid factors: historical perspective, origins and possible role in disease","volume":"32","author":"Williams","year":"1992","journal-title":"J Rheumatol Suppl"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.116.073239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:20:43Z","timestamp":1739902843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624053054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0090955624053054"],"URL":"https:\/\/doi.org\/10.1124\/dmd.116.073239","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereoselective Pharmacokinetics and Chiral Inversion of Ibuprofen in Adjuvant-induced Arthritic Rats","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.116.073239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}